Introduction {#sec1}
============

Cataract is the most common cause of visual impairment in older adults aged 50 years or above, accounting for 33% of visual impairment and 50% of blindness globally \[[@cit0001]\]. Cataract surgery is one of the most common procedures performed worldwide to restore vision and has a high rate of success \[[@cit0002]\]. However, some surgery-related complications may occur during the early postoperative period after cataract surgery, such as endophthalmitis, which could result in an unfavorable visual outcome \[[@cit0003]\]. Furthermore, as the most frequent complication following cataract surgery, increased corneal edema has been witnessed after uneventful phacoemulsification, with an incidence of 14.3% \[[@cit0004]\].

In our population, the older patients who have poor vision owing to senile cataract are usually suffering from other diseases, mostly diabetes mellitus \[[@cit0005], [@cit0006]\]. Previous studies have demonstrated that diabetes changed the structure and function as well as the thickness of corneal endothelial cells \[[@cit0007], [@cit0008]\]. It has also been reported that the presence of macular edema is primarily responsible for the visual outcome after the performance of cataract surgery in diabetic patients \[[@cit0009]\]. The relationship between corneal endothelial cells and diabetes has been investigated in humans and animals. According to the previous research, the coefficient of variation (CV) of cell area from the normal corneal thickness is significantly associated with the duration of diabetes \[[@cit0010]\]. Changes in the integrity of corneal endothelial cells and foveal thickness of the macula have been observed after phacoemulsification in diabetic patients and age-matched controls.

The purpose of this study was to evaluate the natural course of changes in corneal endothelial cells and foveal thickness in diabetic and nondiabetic cataract patients during the postoperative period.

Material and methods {#sec2}
====================

Patients {#sec2.1}
--------

The study recruited consecutive patients with cataract scheduled for routine phacoemulsification and intraocular lens (IOL) implantation in our hospital between January, 2008 and October, 2008. Patients who only underwent the ophthalmic surgery were included. Exclusion criteria included any ocular diseases that might influence the monitoring of corneal endothelial cells such as pterygium, high myopia, endothelial dystrophies, keratitis or keratoconus, and any ocular diseases that might influence macular thickness such as uveitis, age-related macular degeneration, intraoperative complications (such as ruptured membranes of posterior lens capsule, dislocation of the lens nucleus into the vitreous space, or bleeding of the epichoroidal space), and inferior quality measurements of optical coherence tomography (OCT) due to media opacities. Additionally, any patient with a history of cataract surgery in the fellow eye during the previous 6 months was also excluded.

Patients were divided into two groups according to the diagnosis of diabetes mellitus type II: the diabetic group and the nondiabetic group. Screening was continued until 60 eyes from each group (one eye per patient) were included for the study. Demographic data such as age and gender were collected. The severity of diabetes was assessed for the diabetic group by measuring the levels of glycated hemoglobin (HbA~1c~) and plasma glucose. The study was approved by the Regional Ethics Committee of our hospital, and written informed consent was obtained from all patients prior to their inclusion in the study.

Main outcome measures {#sec2.2}
---------------------

All eyes received a complete ophthalmologic examination on preoperative day 1 (baseline), including best corrected visual acuity (BCVA), Amsler chart, slit-lamp examination, intraocular pressure (IOP) measurement, and dilated fundus examination. The BCVA was recorded on a Snellen chart at each visit.

Corneal endothelial injury associated with phacoemulsification was assessed in terms of cell density and morphology. Photographs of the central corneal endothelium were taken by an automatic specular microscope (Noncon Robo-CA Konan SP-9000p Tokyo, Japan) on a minimum of 40 endothelial cells to evaluate the endothelial cell density (ECD), as well as other parameters including CV in endothelial cell size, percentage of hexagonal cells (PHC) and central corneal thickness (CCT) preoperatively and at day 3, 1 week, and 1, 3, and 6 months postoperatively.

Corneal integrity was also examined using the automatic specular microscope (Noncon Robo-CA Konan SP-9000p Tokyo, Japan), and the central foveal thickness (CFT) was measured and analyzed by Stratus OCT (OCT3, software version 4.0.1; Carl Zeiss Meditec, Dublin, California, USA) as previously described by Hayashi *et al.* in 2009 \[[@cit0011]\]. The measurements of corneal integrity and CFT procedures were performed by the same experienced operator immediately before the operation. Three readings were taken for both corneal integrity and OCT, and the average of the three readings was used each time.

Fundus examination was performed at postoperative day 3, 1 week, and 1, 3, and 6 months with full pupil dilation. All patients were examined with fluorescein fundus angiography (FFA) preoperatively and at 12 months postoperatively to confirm the presence of proliferative changes. Macular edema was determined by a physician, also a surgeon, according to four grades: absent (0), focal (1), diffuse (2) and cystoid (3) macular edema \[[@cit0012]\].

Surgical procedures {#sec2.3}
-------------------

During the cataract surgery, all patients received a hydrophobic acrylic IOL implantation (MA60AC or MA50BM; Alcon Laboratories, Fort Worth, TX, USA).

All the procedures were performed by the same surgeon team under sterile conditions. Tropica-mide (0.5%) was given for mydriasis 30 min before surgery. Following topical anesthesia (Alcaine), a 3.2-mm clear corneal incision was made at the temporal side using a diamond blade, and the anterior chamber was filled with 2% methylcellulose (Vistagel, Croma Pharma, Austria). A continuous curvilinear capsulorhexis (approximately 5.0 mm in diameter) was performed with a bent needle under a viscoelastic material. After hydrodissection, phacoemulsification of the nucleus and cortical aspiration was carried out using a keratome. Then the lens capsule was inflated with 1% sodium hyaluronate (Healon; Advanced Medical Optics, Santa Ana, CA, USA), followed by the accurate implantation of acrylic IOL into the capsular bag. Finally, all viscoelastic materials were carefully removed. After the surgery, a non-steroid antiinflammatory drug and ophthalmic corticosteroids (Pranopulin Ophthalmic Solution and Loteprednol Etabonate Ophthalmic Suspension) were given for 4 weeks: 4 times per day for the first week, 3 times per day for the second week, twice per day for the third week, and once per day for the last week.

Follow-up {#sec2.4}
---------

All patients were followed up at day 3, 1 week, 1 month, 3 months and 6 months postoperatively. During their visits, all patients received a complete ophthalmic examination as they did at preoperative day 1. All baseline and postoperative evaluations were performed by an ophthalmologist (W.L.), who was blinded to the presence of diabetes in patients.

Statistical analysis {#sec2.5}
--------------------

All analyses were performed using SPSS 16.0 (SPSS, Inc., Chicago, IL, USA). The quantitative data are shown as mean ± standard deviation (SD), and qualitative data are presented as percentages. Comparisons between the diabetic and nondiabetic groups were analyzed by the two-way ANOVA for quantitative data and the χ^2^ test for qualitative data. Differences were considered statistically significant at *p* \< 0.05.

Results {#sec3}
=======

All the patients completed the 6 months follow-up and were all included in the analyses. The demographic and clinical characteristics of these patients are shown in [Table I](#t0001){ref-type="table"}. The diabetic group had a mean duration of diabetes of 4.4 years, and none of the diabetic patients had any severe diabetic complications previously, such as diabetic nephropathy, diabetic retinopathy, diabetic neuropathy, vasculopathy of lower extremities, cardiovascular disease or diabetic foot. They have kept the diabetes under good control according to the criteria of China guideline for type II diabetes (2013 Edition, [Table II](#t0002){ref-type="table"}) \[[@cit0013]\] by following a healthy diet, exercising regularly and taking oral hypoglycemic agents or insulin treatment. There were no significant differences between diabetic and nondiabetic groups in terms of age, gender, phacoemulsification time, intraocular pressure, nucleus grade, or volume of irrigating solution employed (*p* \> 0.05, [Table I](#t0001){ref-type="table"}). No events occurred during all surgical procedures, and no diabetic patients developed proliferative diabetic retinopathy.

###### 

Demographic and intraoperative data of patients with cataract

  Parameter                                       Nondiabetic group   Diabetic group
  ----------------------------------------------- ------------------- ----------------
  Age \[years\]                                   63.6 ±2.4           62.8 ±2.2
  Gender, *n* (%):                                                    
   Male                                           28 (46.7)           26 (43.3)
   Female                                         32 (53.3)           34 (56.7)
  Duration of diabetes \[years\]                  --                  4.4 ±1.5
  Phacoemulsification time \[min\]                30.8 ±4.2           31.8 ±4.0
  Volume of irrigating solution employed \[ml\]   122.3 ±8.3          126.7 ±7.9
  Intraocular pressure at baseline \[mm Hg\]      16.9 ±2.5           17.6 ±2.3
  Cataract nucleus opalescence (score), *n:*                          
   1                                              14                  12
   2                                              21                  22
   3                                              22                  23
   4                                              3                   3

Data are presented as mean ± SD or percentage.

###### 

Goal of comprehensive control of type II diabetes in China

  Parameter                                                  Target value
  ---------------------------------------------------------- ----------------
  Blood glucose \[mmol/l\][\*](#tf2-1){ref-type="fn"};       
   Fasting                                                   4.4--7.0
   Non-fasting                                               \< 10.0
  Glycosylated hemoglobin (HbA~1c~, %)                       \< 7.0
  Blood pressure \[mm Hg\]                                   \< 140/80
  Total cholesterol (TC) \[mmol/l\]                          \< 4.5
  Triglyceride (TG) \[mmol/l)                                \< 1.5
  Body mass index \[kg/m^2^\]                                \< 24.0
  Urinary albumin/creatinine \[mg/day\]:                     
   Male                                                      \< 2.5 (22.0)
   Female                                                    \< 3.5 (31.0)
  Urinary albumin excretion rate (AER) \[µg/min (mg/day)\]   \< 20.0 (30.0)

Capillary blood glucose.

[Table III](#t0003){ref-type="table"} presents the comparison of mean ECD, PHC, CV, CCT and CFT, and all parameters showed no difference between the nondiabetic and diabetic groups before surgery (*p* \> 0.05). During the 6 months of follow-up, both groups had decreased ECD and PHC and increased CV after surgery ([Figure 1](#f0001){ref-type="fig"}; *F~ECD~* = 151.73, *F~PHC~* = 718.42 and *F~CV~* = 126.42, respectively; all *p*~time~ \< 0.05), and the diabetic group had more changes in ECD, PHC, and CV than the nondiabetic group at each time point postoperatively (*F~ECD~* = 56.03, *F~PHC~* = 382.43 and *F~CV~* = 59.25, respectively; all *p*~group~ \< 0.05). The CCT and CFT fluctuated in both groups during the follow-up ([Figure 2](#f0002){ref-type="fig"}; *F~CCT~* = 87.91 and *F~CFT~* = 441.68, respectively; both *p*~time~ \< 0.05), and the diabetic group had individual peaks of CCT and CFT both at postoperative 1 week. Additionally, the diabetic group had a thicker central cornea during the postoperative 6 months and thicker central fovea within postoperative 1 month than the nondiabetic group (*F~CCT~* = 69.33 and *F~CFT~* = 393.05, respectively; all *p*~group~ \< 0.05; [Table III](#t0003){ref-type="table"}). Finally, the central fovea in both groups gradually recovered to normal thickness from postoperative 3 months. Furthermore, significant interactions of time and group were observed for ECD, CV, PHC, CCT and CFT (*F~ECD~* = 133.04, *F~PHC~* = 545.46, *F~CV~* = 76.96, *F~CCT~* = 52.09 and *F~CFT~* = 423.62, respectively; all *p*~group\ ×\ time~ \< 0.05).

###### 

Changes in corneal endothelial morphology and thickness after cataract surgery

  Parameter                                                Nondiabetic group   Diabetic group    *P*-value
  -------------------------------------------------------- ------------------- ----------------- -----------
  Endothelial cell density \[cells/m^2^\]:                                                       
   Preoperative day 1 (baseline)                           2742.14 ±107.54     2743.56 ±109.23   0.943
   Postoperative day 3                                     2740.92 ±107.32     2628.07 ±124.02   \< 0.001
   Postoperative 1 week                                    2738.36 ±108.23     2575.81 ±129.97   \< 0.001
   Postoperative 1 month                                   2736.85 ±108.89     2524.49 ±132.23   \< 0.001
   Postoperative 3 months                                  2733.97 ±109.12     2505.17 ±146.90   \< 0.001
   Postoperative 6 months                                  2733.73 ±108.98     2503.64 ±104.61   \< 0.001
  Percentage of hexagonal cells (%):                                                             
   Preoperative day 1 (baseline)                           56.95 ±1.61         57.02 ±1.57       0.808
   Postoperative day 3                                     56.71 ±1.62         53.63 ±1.87       \< 0.001
   Postoperative 1 week                                    56.55 ±1.63         51.11 ±1.49       \< 0.001
   Postoperative 1 month                                   56.46 ±1.65         49.42 ±1.00       \< 0.001
   Postoperative 3 months                                  56.42 ±1.64         49.30 ±1.03       \< 0.001
   Postoperative 6 months                                  56.37 ±1.66         49.26 ±1.05       \< 0.001
  Coefficient of variation in endothelial cell size (%):                                         
   Preoperative day 1 (baseline)                           43.29 ±1.85         43.52 ±2.00       0.533
   Postoperative day 3                                     43.41 ±1.80         45.83 ±2.89       \< 0.001
   Postoperative 1 week                                    43.63 ±1.84         46.85 ±3.11       \< 0.001
   Postoperative 1 month                                   43.80 ±1.88         48.60 ±3.84       \< 0.001
   Postoperative 3 months                                  43.95 ±1.92         49.00 ±3.80       \< 0.001
   Postoperative 6 months                                  43.97 ±1.89         49.11 ±3.83       \< 0.001
  Central corneal thickness \[µm\]:                                                              
   Preoperative day 1 (baseline)                           511.58 ±13.59       513.36 ±16.16     0.519
   Postoperative day 3                                     512.80 ±13.86       540.07 ±20.70     \< 0.001
   Postoperative 1 week                                    512.69 ±13.46       547.95 ±27.26     \< 0.001
   Postoperative 1 month                                   506.49 ±9.05        540.27 ±20.79     \< 0.001
   Postoperative 3 months                                  506.46 ±8.53        511.90 ±15.71     0.022
   Postoperative 6 months                                  502.37 ±4.28        513.44 ±16.10     \< 0.001
  Central foveal thickness \[µm\]:                                                               
   Preoperative day 1 (baseline)                           195.03 ±2.91        194.97 ±2.87      0.908
   Postoperative day 3                                     195.53 ±2.75        208.86 ±5.30      \< 0.001
   Postoperative 1 week                                    195.53 ±2.75        232.98 ±11.79     \< 0.001
   Postoperative 1 month                                   195.89 ±2.70        217.25 ±7.45      \< 0.001
   Postoperative 3 months                                  195.84 ±2.64        195.74 ±2.64      0.850
   Postoperative 6 months                                  195.02 ±2.90        195.00 ±2.87      0.959

Data are presented as mean ± SD. Differences were considered statistically significant at p \< 0.05.

![Comparisons of endothelial cell density (A), percentage of hexagonal cells (B), and coefficient of variation (C) between the diabetic and nondiabetic groups at preoperative day 1 and postoperative day 3, 1 week, 1 month, 3 months, and 6 months. Data are shown as mean ± standard error (SE). \*Diabetic group differed from nondiabetic group postoperatively at the time point (*p*group \< 0.05)](AMS-14-28826-g001){#f0001}
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Discussion {#sec4}
==========

This study evaluated the natural course of changes in corneal endothelial cells and foveal thickness in diabetic and nondiabetic patients after cataract surgery. The results showed that corneal integrity significantly changed in both nondiabetic and diabetic groups after surgery and that ECD, PHC, CV, CCT and CFT were obviously different in the diabetic and nondiabetic groups during the postoperative observation period.

The corneal endothelium is the innermost layer of the cornea that comprises a monolayer of flat, nonmitotic polygonal cells (mostly hexagonal cells) and is essential for maintenance of normal corneal hydration, thickness and transparency by its barrier and pump functions \[[@cit0014], [@cit0015]\]. Corneal endothelial cells are embryologically derived from the neural crest \[[@cit0016]\]. They can secrete mucopolysaccharide stromal collagen fibers at an osmotic pressure of 60 mm Hg to maintain the relatively dehydrated state; hence, a finite number of endothelial cells is the key to the corneal epithelium and its normal transit function \[[@cit0017], [@cit0018]\]. However, they can be damaged by injury and pathologies such as intraocular surgery and Fuchs dystrophy, but are not regenerated due to their very limited proliferative capacity \[[@cit0019]\]. Many studies have confirmed that endothelial cells cannot regenerate but migrate and expand through the elastic layer around the cell to compensate for the loss of endothelial cells \[[@cit0020]\]. Over the course of this expansion, irreversible edema and opacity might develop in the cornea, which is a serious eye condition. The loss of corneal endothelial cells is influenced by various factors, such as surgeon's experience, hardness of cataract, type of corneal incision, age and preoperative visual acuity \[[@cit0021]\]. Therefore, corneal ECD is often detected in intraocular surgery to guide the choice of surgical approach, especially before and after surgery for cataracts, glaucoma and other significant disorders.

Also, the cell area was an important indicator for the evaluations of endothelial cell function and corneal functional recovery. A high CV of the endothelial deformation index indicated that cells were of varying size and that there were large size differences between them. Therefore, the increase in CV of the corneal endothelial cell area was a sensitive indicator of corneal endothelial cell rearrangement \[[@cit0022]\], whereas the corneal thickness was an important indicator of endothelial function \[[@cit0023]\]. As shown in this study, the diabetic group had more changes in ECD, PHC and CV after surgery compared with the nondiabetic group, suggesting that endothelial cells have been migrating and expanding after their loss, and this rearrangement could be affected by diabetes.

In this study, diabetic patients have poor corneal endothelial function as evidenced by the higher CCT during the 6 months postoperatively compared with the nondiabetic group. In general, the cornea depends on endothelial cell sodium-potassium ATPase pumps to maintain the balance of the matrix of ions and water. The cornea is always in a relatively dehydrated state, which maintains its transparency. Na^+^/K^+^ ATPase activity leading to cell pump dysfunction is an important mechanism of diabetic corneal edema. Similarly, Herse found that 69% to 76% of endothelial cells in diabetic animal models had reduced Na^+^/K^+^ ATP enzyme activity \[[@cit0024]\], which could cause diabetic corneal thickening, not because of the increase in matrix components but due to the increase in water penetration. Moreover, postoperative corneal edema has been associated with many specific factors, for example, Tsaousis *et al.* found that ultrasound energy was a defining factor for the development of corneal edema apart from diabetes mellitus type II, although the consumed ultrasound energy did not define the final clinical outcome \[[@cit0004]\].

In this study, the increase in CFT within 1 month postoperatively was greater in patients with diabetes than those without diabetes, indicating that diabetic macular edema occurred after cataract surgery and was worse in eyes with diabetes. Then, CFT in both groups gradually recovered to normal at postoperative 3 months. This could be demonstrated by previous research in which diabetic macular edema developed in approximately 20--40% of patients receiving cataract surgery, but the macular edema resolved spontaneously in a considerable percentage of these patients \[[@cit0012], [@cit0025]\]. These findings indicated the presence of macular thickening usually following cataract surgery and its regression with time in most diabetic patients. However, diabetic maculopathy actually progresses in some diabetic patients. Both types of macular changes are more prominent in patients with diabetes than those without.

Patients with diabetes who have a normal corneal epithelium, epithelial basement membrane and basement membrane complex may experience morphological changes in the basal layer and endothelium because their own balance of these structures is changed. These changes cause the primary or secondary (surgery) corneal changes, which is why it is more difficult for patients with diabetes to withstand the trauma of eye surgery.

There were several limitations in this study. For example, HbA~1c~ and the mean value of blood glucose levels were not analyzed although these diabetic patients have kept the diabetes under good control. Also, perioperative and postoperative glucose variability were not detected, and further study is needed to investigate whether glucose variability is an effective factor for postoperative changes in diabetic patients. Notwithstanding its limitations, this study demonstrated that diabetic patients were prone to have more changes in the corneal endothelial morphology and thickness, and an increased foveal thickness after phacoemulsification with implantation of a foldable IOL compared to nondiabetic patients. Therefore, one should be alert when performing phacoemulsification surgery in diabetic patients with cataract to prevent the direct effects of the acoustic vibration, heat, and objects.
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